Table 1

Comparisons of serum CCL2, CCL18, and VEGF levels between gastric cancer patients and control groups
N Mean (pg/ml) Std. deviation P
CCL2 < 0.001
Patients 60 25.05 1.22
Controls 20 15.95 1.15
CCL18 < 0.001
Patients 60 115.94 22.56
Controls 20 42.46 13.97
VEGF < 0.001
Patients 60 132.92 10.50
Controls 20 59.02 6.28

Wu et al.

Wu et al. BMC Clinical Pathology 2013 13:15   doi:10.1186/1472-6890-13-15

Open Data